Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pulmonary Embolism (Disorder)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableStudy completedNCT00266045
What this trial is testing

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 355
Post-approval studies (Phase 4)UnknownNCT02979561
What this trial is testing

Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Who this might be right for
Angiographically Confirmed Acute Massive Pulmonary Embolism Treated With Endovascular Mechanical Fragmentation and Thrombolytic Therapy
Meshalkin Research Institute of Pathology of Circulation 200
Large-scale testing (Phase 3)Study completedNCT02064439
What this trial is testing

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Who this might be right for
Pulmonary EmbolismThromboembolismThrombosis+2 more
Bayer 3,365
Not applicableStudy completedNCT00011180
What this trial is testing

Risk Factors for Venous Thromboembolism in the Community

Who this might be right for
Cardiovascular DiseasesThromboembolism
Mayo Clinic 385
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableStudy completedNCT05413317
What this trial is testing

Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence

Who this might be right for
Pulmonary Embolism
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 115
Not applicableStudy completedNCT02345343
What this trial is testing

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 100
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableUnknownNCT00261014
What this trial is testing

Understanding Risk Factors Involved in Developing a Second Blood Clot.

Who this might be right for
Deep Vein Thrombosis
Ottawa Hospital Research Institute 800
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Large-scale testing (Phase 3)Ended earlyNCT01164046
What this trial is testing

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Who this might be right for
Venous ThromboembolismNeoplasms
University Medical Center Groningen 56
Very early researchLooking for participantsNCT06886516
What this trial is testing

Apixaban in Thrombocytopenia

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism and ThrombosisThrombocytopenia+1 more
Rushad Patell 30
Not applicableStudy completedNCT07356908
What this trial is testing

Impact of Sleep Related Breathing Disorders on Outcomes of Acute Pulmonary Embolism

Who this might be right for
Pulmonary EmbolismSleep Apnea Syndrome (OSAS)
Alexandria University 40
Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Large-scale testing (Phase 3)Study completedNCT01285661
What this trial is testing

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

Who this might be right for
Deep Vein Thrombosis of Lower LimbLower Extremity Deep Venous Thrombosis Recurrent
University of Padova 584
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Load More Results